Release Date: 13/11/13 15:06 Summary: Disagreement with 3TL Regarding Vesting of Options Price Sensitive: Yes Download Document 116.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%